Literature DB >> 31100636

Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths.

Joshua A Barocas1, Jianing Wang2, Brandon D L Marshall3, Marc R LaRochelle4, Amy Bettano5, Dana Bernson5, Curt G Beckwith6, Benjamin P Linas2, Alexander Y Walley4.   

Abstract

BACKGROUND AND AIMS: While prescribed and illicit opioid use are primary drivers of the national surges in overdose deaths, opioid overdose deaths in which stimulants are also present are increasing in the U.S. We determined the social determinants and sociodemographic factors associated with opioid-only versus polysubstance opioid overdose deaths in Massachusetts. Particular attention was focused on the role of stimulants in opioid overdose deaths.
METHODS: We analyzed all opioid-related overdose deaths from 2014 to 2015 in an individually-linked population database in Massachusetts. We used linked postmortem toxicology data to identify drugs present at the time of death. We constructed a multinomial logistic regression model to identify factors associated with three mutually exclusive overdose death groups based on toxicological results: opioid-related deaths with (1) opioids only present, (2) opioids and other substances not including stimulants, and (3) opioids and stimulants with or without other substances.
RESULTS: Between 2014 and 2015, there were 2,244 opioid-related overdose deaths in Massachusetts that had accompanying toxicology results. Toxicology reports indicated that 17% had opioids only, 36% had opioids plus stimulants, and 46% had opioids plus another non-stimulant substance. Persons older than 24 years, non-rural residents, those with comorbid mental illness, non-Hispanic black residents, and persons with recent homelessness were more likely than their counterparts to die with opioids and stimulants than opioids alone.
CONCLUSIONS: Polysubstance opioid overdose is increasingly common in the US. Addressing modifiable social determinants of health, including barriers to mental health services and homelessness, is important to reduce polysubstance use and overdose deaths.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amphetamines; Cocaine; Opioid-related overdose; Polysubstance use; Stimulants

Mesh:

Substances:

Year:  2019        PMID: 31100636      PMCID: PMC6588486          DOI: 10.1016/j.drugalcdep.2019.03.014

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  18 in total

1.  Patterns of drug use and HIV infection among adults in a nationally representative sample.

Authors:  Stephanie Shiau; Stephen M Arpadi; Michael T Yin; Silvia S Martins
Journal:  Addict Behav       Date:  2017-01-07       Impact factor: 3.913

2.  Increases from 2002 to 2015 in prescription opioid overdose deaths in combination with other substances.

Authors:  Denise B Kandel; Mei-Chen Hu; Pamela Griesler; Melanie Wall
Journal:  Drug Alcohol Depend       Date:  2017-07-04       Impact factor: 4.492

3.  Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington.

Authors:  Sara Nelson Glick; Richard Burt; Kim Kummer; Joe Tinsley; Caleb J Banta-Green; Matthew R Golden
Journal:  Drug Alcohol Depend       Date:  2017-11-16       Impact factor: 4.492

4.  Trends in U.S. Drug Overdose Deaths in Non-Hispanic Black, Hispanic, and Non-Hispanic White Persons, 2000-2015.

Authors:  Meredith S Shiels; Neal D Freedman; David Thomas; Amy Berrington de Gonzalez
Journal:  Ann Intern Med       Date:  2017-12-05       Impact factor: 25.391

5.  Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids.

Authors:  Christopher McCall Jones; Grant T Baldwin; Wilson M Compton
Journal:  Am J Public Health       Date:  2017-03       Impact factor: 9.308

6.  The impact of benzodiazepine use on methadone maintenance treatment outcomes.

Authors:  Bruna Brands; Joan Blake; David C Marsh; Beth Sproule; Renuka Jeyapalan; Selina Li
Journal:  J Addict Dis       Date:  2008

7.  Cross-sectional cause of death comparisons for stimulant and opioid mortality in San Francisco, 2005-2015.

Authors:  Caitlin Turner; Dharsan Chandrakumar; Christopher Rowe; Glenn-Milo Santos; Elise D Riley; Phillip O Coffin
Journal:  Drug Alcohol Depend       Date:  2018-02-21       Impact factor: 4.492

8.  Multiple Fentanyl Overdoses - New Haven, Connecticut, June 23, 2016.

Authors:  Anthony J Tomassoni; Kathryn F Hawk; Karen Jubanyik; Daniel P Nogee; Thomas Durant; Kara L Lynch; Rushaben Patel; David Dinh; Andrew Ulrich; Gail D'Onofrio
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-02-03       Impact factor: 17.586

9.  Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis.

Authors:  Eric C Sun; Anjali Dixit; Keith Humphreys; Beth D Darnall; Laurence C Baker; Sean Mackey
Journal:  BMJ       Date:  2017-03-14

10.  Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.

Authors:  Puja Seth; Lawrence Scholl; Rose A Rudd; Sarah Bacon
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-03-30       Impact factor: 17.586

View more
  33 in total

1.  Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases.

Authors:  David P Serota; Joshua A Barocas; Sandra A Springer
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

2.  Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance overdose, North Carolina, 2009-2018.

Authors:  Mary C Figgatt; Anna E Austin; Mary E Cox; Scott Proescholdbell; Stephen W Marshall; Rebecca B Naumann
Journal:  Drug Alcohol Depend       Date:  2021-01-02       Impact factor: 4.492

3.  Impact of Substance Use Disorder on Midterm Mortality After Valve Surgery for Endocarditis.

Authors:  Alysse G Wurcel; Griffin Boll; Deirdre Burke; Rani Khetarpal; Patrick J Warner; Alice M Tang; Kenneth G Warner
Journal:  Ann Thorac Surg       Date:  2019-10-17       Impact factor: 4.330

4.  Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18.

Authors:  Bradley D Stein; Christopher M Jones; Rosanna Smart; Flora Sheng; Mark Sorbero
Journal:  Drug Alcohol Depend       Date:  2021-02-03       Impact factor: 4.492

5.  The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose.

Authors:  Ruchir N Karmali; G Thomas Ray; Andrea L Rubinstein; Stacy A Sterling; Constance M Weisner; Cynthia I Campbell
Journal:  Drug Alcohol Depend       Date:  2020-02-20       Impact factor: 4.492

6.  Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida.

Authors:  Amanda Sharp; Melissa Carlson; Veronica Howell; Kathleen Moore; Zev Schuman-Olivier
Journal:  J Subst Abuse Treat       Date:  2020-12-11

7.  Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast.

Authors:  Pablo K Valente; Angela R Bazzi; Ellen Childs; Peter Salhaney; Joel Earlywine; Jennifer Olson; Dea L Biancarelli; Brandon D L Marshall; Katie B Biello
Journal:  Int J Drug Policy       Date:  2020-09-07

8.  Ecological momentary assessment of daily drug use and harm reduction service utilization among people who inject drugs in non-urban areas: A concurrent mixed-method feasibility study.

Authors:  Katie Biello; Peter Salhaney; Pablo K Valente; Ellen Childs; Jennifer Olson; Joel J Earlywine; Brandon Dl Marshall; Angela R Bazzi
Journal:  Drug Alcohol Depend       Date:  2020-07-10       Impact factor: 4.492

9.  Hospitalization outcomes of people who use drugs: One size does not fit all.

Authors:  Elisabeth Merchant; Deirdre Burke; Leah Shaw; Hansel Tookes; Dustin Patil; Joshua A Barocas; Alysse G Wurcel
Journal:  J Subst Abuse Treat       Date:  2020-01-22

10.  Patterns of substance use before and after hospitalization among patients seen by an inpatient addiction consult service: A latent transition analysis.

Authors:  Caroline King; Christina Nicolaidis; P Todd Korthuis; Kelsey C Priest; Honora Englander
Journal:  J Subst Abuse Treat       Date:  2020-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.